ULBI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Ultralife Corp (ULBI) is not a strong buy for a beginner, long-term investor at this moment. While there is insider buying activity and a slight revenue increase, the company's financials show significant net income and EPS declines, and the technical indicators do not provide a strong bullish signal. Additionally, there are no recent positive news catalysts or trading signals to support immediate action.
The MACD is slightly positive and expanding, indicating mild bullish momentum. RSI is neutral at 59.279, and moving averages are converging, showing no clear trend. Key resistance levels are at 6.76 and 6.943, with support at 6.166 and 5.982. Overall, the technical indicators suggest a lack of strong directional movement.
Insider buying has increased by 315.93% over the last month, which may indicate confidence in the company's future.
No recent news or external catalysts to drive the stock price higher. Stock trend analysis suggests a potential decline in the short term (-3.76% in the next week, -3.52% in the next month).
In Q4 2025, revenue increased by 10.56% YoY to $48,481,000, but net income dropped significantly to -$7,422,000 (-3925.77% YoY), and EPS fell to -0.45 (-4600.00% YoY). Gross margin improved slightly to 24.87% (up 2.90% YoY).
No analyst ratings or price target changes available for Ultralife Corp at this time.
